Jordan Deaner is an Ophthalmology physician affiliated with Thomas Jefferson University. OpenAlex indexes 68 publications with 356 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
840 Walnut St Ste 1020
Philadelphia, PA 191075109
Telephone
800-331-6634Provider last certified this registry record 17 Aug 2022.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ANI Pharmaceuticals, Inc.Program year202523 payments$39,798openpaymentsdata.cms.gov ↗
- Bausch & Lomb Americas Inc.Program year202520 payments$21,815openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202513 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
73.9%Antineovascularisation agents69.8%Faricimab-svoa100%Part B, office-administered≥37 patientsCorticosteroid2.4%Prednisolone Acetate96%Fluorometholone4%Part D<11 patients+ 7 more classes in this area
Dermatology
14.8%Corticosteroid14.8%Triamcinolone acetonide67%Fluocinolone acetonide33%Part B, office-administered≥30 patientsCancer & immunology
9%Vascular Endothelial Growth Factor Inhibitor9%Aflibercept100%Part B, office-administered≥143 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical Outcomes of Ocular Toxoplasmosis–Associated Rhegmatogenous and Tractional Retinal Detachment
Journal of VitreoRetinal Diseases
2026 - Seasonal Incidence of New Uveitis Diagnoses Across the United States
Ocular Immunology and Inflammation
2026 - Influence of Social Determinants of Health on Presenting Visual Acuity in Retinal Vein Occlusions
Ophthalmology Science
2026
Similar KOLs
Other experts from the same institution or the same specialty.
David Whellan, MD
Thomas Jefferson University
Jesse Roman, MD
Thomas Jefferson University
Stephen Silberstein, MD
Thomas Jefferson University
David Cognetti, MD
Thomas Jefferson University
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”